Phacilitate Leaders Forum

29TH - 30TH SEPTEMBER 2020


Sponsors & Exhibitors 2018

Brightlands Chemelot Campus

Associate Sponsor

Brightlands Chemelot Campus is an Open Innovation Campus offering Real Estate, Venture Capital and Business Development services. Within its Biomedical Materials focus we work specifically in the field of Regenerative Medicine, Tissue Engineering and Medical Devices.

Located at the axis of the cross-border region Netherlands-Belgium-Germany, the campus is a stepping stone for European expansion.

In 2013, Brightlands Chemelot Campus started the construction of Regeneration Street: 50,000m2 of world-leading research, production and innovation in Regenerative Medicine across several state-of-the-art high-tech buildings. The first building is an advanced facility for cell therapy and regenerative medicine. The building has a total ground floor size of 2,400m2 with 750m2 clean room facilities.

We are currently rapidly expanding the Lonza facilities to accommodate their growth. In parallel we are developing a new GMP certified facility for startups and SME’s with a total footprint of 4,000m2.

Visit Website
View all Sponsors & Exhibitors 2018
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd